| |
Group A (LGE + , EF < 50%) n = 8
|
Group B (LGE + , EF ≥ 50%) n = 13
|
Group C (LGE−, EF ≥ 50%) n = 30
|
Controls n = 18
|
p (A vs. controls)
|
p (B vs controls)
|
p (C vs. controls)
|
|---|
|
GLS (%)
|
− 14.94 ± 1.91
|
− 19.14 ± 2.57
|
− 21.9 ± 4.12
|
− 20.91 ± 3.05
|
3.10–4
|
0.39
|
0.70
|
|
GCS (%)
|
− 14.71 ± 4.18
|
− 24.81 ± 5.74
|
− 26.17 ± 4.19
|
− 30.03 ± 5.12
|
1.10–8
|
0.013
|
0.033
|
|
GRS (%)
|
38.3 ± 9.80
|
50.45 ± 14.22
|
60.02 ± 15.21
|
67.41 ± 10.67
|
1.10–5
|
3.10–3
|
0.21
|
|
MAPSE (mm)
|
10.50 ± 1.10
|
10.77 ± 1.55
|
11.63 ± 1.88
|
13.66 ± 2.70
|
2.10–3
|
7.10–4
|
5.10–3
|
|
MAPSE lateral (mm)
|
11.00 ± 1.31
|
11.31 ± 2.18
|
12.60 ± 2.24
|
14.44 ± 3.27
|
5.10–3
|
3.10–3
|
0.05
|
|
MAPSE septal (mm)
|
10.00 ± 1.07
|
10.23 ± 1.59
|
10.67 ± 1.83
|
12.88 ± 2.33
|
2.10–3
|
9.10–4
|
9.10–4
|
- Variables are expressed as the mean ± standard deviation
- Variables marked in bold have their ANOVA p value < 0.05
- P values of the Dunnet post hoc test < 0.05 are marked in bold
- LGE +, positive late gadolinium enhancement; LGE–, negative late gadolinium enhancement; LV, left ventricle; EF, ejection fraction; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; MAPSE, mitral annular plane systolic excursion
